<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Quinazoline</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Quinazoline">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/mediawiki.page.gallery.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/mediawiki.page.gallery.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Quinazoline</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Quinazoline</b> is an organic compound with the formula C<sub>8</sub>H<sub>6</sub>N<sub>2</sub>. It is an aromatic heterocycle with a bicyclic structure consisting of two fused six-membered aromatic rings, a <a href="Benzene.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzene" title="Benzene">benzene</a> ring and a <a href="Pyrimidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Pyrimidine" title="Pyrimidine">pyrimidine</a> ring.  It is a light yellow crystalline solid that is soluble in water. Also known as 1,3-diazanaphthalene, quinazoline received its name from being an aza derivative of <a href="Quinoline.htm" tppabs="https://ptable.com/wiki/compounds/A/Quinoline" title="Quinoline">quinoline</a>. Though the parent quinazoline molecule is rarely mentioned by itself in technical literature, substituted derivatives have been synthesized for medicinal purposes such as antimalarial and anticancer agents.  Quinazoline is a planar molecule. It is isomeric with the other diazanaphthalenes of the benzodiazine subgroup: cinnoline, <a href="Quinoxaline.htm" tppabs="https://ptable.com/wiki/compounds/A/Quinoxaline" title="Quinoxaline">quinoxaline</a>, and <a href="Phthalazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Phthalazine" title="Phthalazine">phthalazine</a>. Over 200 biologically active quinazoline and quinoline alkaloids are identified.<span class="mw-ref" id="cite_ref-3"><a href="#cite_note-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-4"><a href="#cite_note-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>

<span>
</span><table class="infobox bordered" style="border-collapse:collapse; width:22em; text-align:left; ;">
<caption style="text-align:center;">Quinazoline</caption>
<tbody><tr> 
<td colspan="2" style="text-align:center; padding:2px;"><figure-inline><img src="../I/m/Quinazoline_numbering.png" tppabs="https://ptable.com/wiki/compounds/I/m/Quinazoline_numbering.png" data-file-width="317" data-file-height="230" data-file-type="bitmap" height="73" width="100"></figure-inline></td></tr>
<tr>

<td colspan="2" class="borderless" style="text-align:center">
<table border="0" style="width:100%;">
<tbody><tr><td style="border-right:1px solid #aaa;"><center><div class="thumb tnone"></div><div class="thumbinner" style="width:112px"><img src="../I/m/Quinazoline-3D-balls.png" tppabs="https://ptable.com/wiki/compounds/I/m/Quinazoline-3D-balls.png" data-file-width="2000" data-file-height="1591" data-file-type="bitmap" height="88" width="110"><div class="thumbcaption" style="text-align: left">C=black, H=white, N=blue</div></div></center></td>

<td><center><div class="thumb tnone"></div><div class="thumbinner" style="width:112px"><img src="../I/m/Quinazoline-3D-spacefill.png" tppabs="https://ptable.com/wiki/compounds/I/m/Quinazoline-3D-spacefill.png" data-file-width="2000" data-file-height="1687" data-file-type="bitmap" height="93" width="110"><div class="thumbcaption" style="text-align: left">C=black, H=white, N=blue</div></div></center></td></tr>
</tbody></table></td></tr>

<tr>
<th colspan="2" style="background: #f8eaba; text-align: center;">Names</th></tr>

<tr>

<td colspan="2" style="text-align:left;">IUPAC name
<div style="max-width:22em; word-wrap:break-word; padding-left:1.7em;">Quinazoline</div></td></tr>

<tr>


<td colspan="2" style="text-align:left;">Other names
<div style="max-width:22em; word-wrap:break-word; padding-left:1.7em;">1,3-diazanaphthalene
<p>benzopyrimidine</p>

<p>phenmiazine</p>
benzo-1,3-diazine</div></td></tr>

<tr>
<th colspan="2" style="background: #f8eaba; text-align: center;">Identifiers</th></tr>

<tr>

<td><div style="padding:0.1em 0;line-height:1.2em;">CAS Number</div></td>
<td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=253-82-7  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=253-82-7'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=253-82-7" class="external text external">253-82-7</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr>

<tr>
<td><div style="padding:0.1em 0;line-height:1.2em;">3D model (JSmol)</div></td>
<td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=c1ccc2c%28c1%29cncn2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=c1ccc2c%28c1%29cncn2'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=c1ccc2c%28c1%29cncn2" class="external text external">Interactive image</a></span></li></ul></div></td></tr>

<tr>



<td>ChEBI</td>
<td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=36621  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=36621'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=36621" class="external text external">CHEBI:36621</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr>

<tr>
<td>ChEMBL</td>
<td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL301359  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL301359'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL301359" class="external text external">ChEMBL301359</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr>

<tr>
<td>ChemSpider</td>
<td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.8855.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.8855.html'" tppabs="http://www.chemspider.com/Chemical-Structure.8855.html" class="external text external">8855</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr>

<tr>

<td><span>ECHA InfoCard</span></td>
<td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.005.424  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.005.424'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.005.424" class="external text external">100.005.424</a></td></tr>
<tr>
<td><span>EC Number</span></td>
<td><div class="plainlist"><ul><li>205-965-3</li></ul></div></td></tr>

<tr>





<td><div style="padding:0.1em 0;line-height:1.2em;">PubChem <abbr>CID</abbr></div></td>
<td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/9210  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/9210'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/9210" class="external text external">9210</a></span></li></ul></div></td></tr>

<tr>

<td>UNII</td>
<td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=UB9QUR18NL  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=UB9QUR18NL'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=UB9QUR18NL" class="external text external">UB9QUR18NL</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr>

<tr>

<td><div style="padding:0.1em 0;line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></div></td>
<td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID7075214  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID7075214'" tppabs="https://comptox.epa.gov/dashboard/DTXSID7075214" class="external text external">DTXSID7075214</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr>

<tr>
<td colspan="2"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left; text-align:left; font-weight:normal; background:transparent;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="border-top:1px solid #ccc; padding:0.2em 0 0.2em 1.5em; text-align:left;"><div style="word-wrap:break-word; text-indent:-1.5em; font-size:11px; line-height:120%;">InChI=1S/C8H6N2/c1-2-4-8-7(3-1)5-9-6-10-8/h1-6H<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div><div style="word-wrap:break-word; text-indent:-1.5em; font-size:11px; line-height:120%;">Key:<span>&nbsp;</span>JWVCLYRUEFBMGU-UHFFFAOYSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></div></li><li style="line-height: inherit; margin: 0"><div style="border-top:1px solid #ccc; padding:0.2em 0 0.2em 1.5em; text-align:left;"><div style="word-wrap:break-word; text-indent:-1.5em; font-size:11px; line-height:120%;">InChI=1/C8H6N2/c1-2-4-8-7(3-1)5-9-6-10-8/h1-6H</div><div style="word-wrap:break-word; text-indent:-1.5em; font-size:11px; line-height:120%;">Key:<span>&nbsp;</span>JWVCLYRUEFBMGU-UHFFFAOYAV</div></div></li></ul>
</div></td></tr>
<tr>
<td colspan="2"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left; text-align:left; font-weight:normal; background:transparent;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="border-top:1px solid #ccc; padding:0.2em 0 0.2em 1.6em; word-wrap:break-word; text-indent:-1.5em; text-align:left; font-size:11px; line-height:120%;">c1ccc2c(c1)cncn2</div></li></ul>
</div></td></tr>

<tr>
<th colspan="2" style="background: #f8eaba; text-align: center;">Properties</th></tr>

<tr>
<td><div style="padding:0.1em 0;line-height:1.2em;">Chemical formula</div></td>

<td><span>C</span><sub>8</sub><span>H</span><sub>6</sub><span>N</span><sub>2</sub></td></tr>

<tr>
<td>Molar mass</td>

<td><span class="nowrap">130.150</span><span>&nbsp;</span>g·mol<sup>−1</sup> <span> </span></td></tr>

<tr>
<td>Appearance</td>
<td>light yellow crystals</td></tr>
<tr>

<td>Density</td>
<td>1.351 g/cm<sup>3</sup>, solid</td></tr>
<tr>
<td>Melting point</td>
<td><span> </span>48<span>&nbsp;</span>°C (118<span>&nbsp;</span>°F; 321<span>&nbsp;</span>K)<span> </span></td></tr>

<tr>
<td>Boiling point</td>
<td><span> </span>243<span>&nbsp;</span>°C (469<span>&nbsp;</span>°F; 516<span>&nbsp;</span>K)<span> </span></td></tr>

<tr>


<td><div style="padding:0.1em 0;line-height:1.2em;">Solubility in water</div></td>
<td>Soluble</td></tr>
<tr>












<td>Acidity (p<i>K</i><sub>a</sub>)</td>
<td>3.51<span class="mw-ref" id="cite_ref-Armarego_1-0"><a href="#cite_note-Armarego-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></td></tr>
<tr>
<th colspan="2" style="background: #f8eaba; text-align: center;">Structure</th></tr>

<tr>









<td><div style="padding:0.1em 0;line-height:1.2em;">Dipole moment</div></td>
<td>2.2 D<span class="mw-ref" id="cite_ref-Houben-Weyl_2-0"><a href="#cite_note-Houben-Weyl-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></td></tr>
<tr>

<th colspan="2" style="background: #f8eaba; text-align: center;">Hazards</th></tr>

<tr>
<td>Main hazards</td>
<td>Irritant</td></tr>
<tr>
<td>Safety data sheet</td>
<td><a href="javascript:if(confirm('https://fscimage.fishersci.com/msds/97621.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fscimage.fishersci.com/msds/97621.htm'" tppabs="https://fscimage.fishersci.com/msds/97621.htm" class="external text external">External MSDS</a></td></tr>
<tr>




<td>S-phrases <span style="background:moccasin; line-height:85%;"><small title="Per CLP Regulation, outdated per 1 June 2017. Replaced by GHS data"><i>(outdated)</i></small></span></td>
<td><abbr class="abbr">S24</abbr> <abbr class="abbr">S25</abbr></td></tr>
<tr>





<td>Flash point</td>
<td><span> </span>106<span>&nbsp;</span>°C (223<span>&nbsp;</span>°F; 379<span>&nbsp;</span>K)<span> </span></td></tr>

<tr>





<td colspan="2" style="text-align:left; background:#f8eaba;"><div style="margin:0 auto; text-align:left;"><div style="padding:0.1em 0;line-height:1.2em;">Except where otherwise noted, data are given for materials in their standard state (at 25<span>&nbsp;</span>°C [77<span>&nbsp;</span>°F], 100<span>&nbsp;</span>kPa).</div></div></td></tr>

<tr style="background:#f8eaba; border-top:2px solid transparent;">
<td colspan="2" style="text-align:center;"><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="12" width="12"></span></figure-inline><span style="display:none">Y</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=464378503&page2=Quinazoline  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=464378503&page2=Quinazoline'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=464378503&page2=Quinazoline" class="external text external">verify</a></span><span>&nbsp;</span>(what is<span>&nbsp;</span><sup><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup><span>&nbsp;</span>?)</td></tr>

<tr style="background:#f8eaba; border-top:2px solid transparent;">
<td colspan="2" style="text-align:center;">Infobox<span>&nbsp;</span>references</td></tr>

<tr style="background:#f8eaba;">
<td style="width:40%; max-height:1px; border-top:2px solid transparent; border-right:1px solid transparent;"></td>
<td style="width:60%; max-height:1px; border-top:2px solid transparent; border-left:1px solid transparent;"></td></tr>


</tbody></table>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Synthesis_and_reactions">Synthesis and reactions</h2></summary>
    
<p>The first known synthesis of quinazoline was reported in 1895 by August Bischler and Lang through the decarboxylation of the 2-carboxy derivative (quinazoline-2-carboxylic acid).<span class="mw-ref" id="cite_ref-Asif_5-0"><a href="#cite_note-Asif-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> In 1903, Siegmund Gabriel reported the synthesis of the parent quinazoline from <i>o</i>-nitrobenzylamine, which was reduced with hydrogen iodide and red phosphorus to 2-amino<a href="Benzylamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Benzylamine" title="Benzylamine">benzylamine</a>. The reduced intermediate condenses with formic acid to yield dihydroquinazoline, which was oxidized to quinazoline.<span class="mw-ref" id="cite_ref-Abstracts_6-0"><a href="#cite_note-Abstracts-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Hydrolysis">Hydrolysis</h3></summary>
    
<p>Quinazoline hydrolyzes under acidic and alkaline conditions to 2-aminobenzaldehyde and <a href="Formic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Formic_acid" title="Formic acid">formic acid</a> and ammonia/ammonium.<span class="mw-ref" id="cite_ref-Houben-Weyl_2-1"><a href="#cite_note-Houben-Weyl-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Electrophilic_and_nucleophilic_substitution">Electrophilic and nucleophilic substitution</h3></summary>
    
<p>The pyrimidine ring resists electrophilic substitution, although the 4-position is more reactive than the 2-position. In comparison, the benzene ring is more susceptible to electrophilic substitution. The ring position order of reactivity is 8 &gt; 6 &gt; 5 &gt; 7. 2- and 4-halo derivatives of quinazoline undergo displacement by nucleophiles, such as piperidine.<span class="mw-ref" id="cite_ref-Houben-Weyl_2-2"><a href="#cite_note-Houben-Weyl-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Biological_and_pharmacological_significance">Biological and pharmacological significance</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Gefitinib">Gefitinib</h3></summary>
    
<p>In May 2003, the U.S. Food and Drug Administration (FDA) approved a quinazoline-containing drug <a href="Gefitinib.htm" tppabs="https://ptable.com/wiki/compounds/A/Gefitinib" title="Gefitinib">gefitinib</a>. The drug, produced by AstraZeneca, is an inhibitor of the protein kinase of epidermal growth factor receptor (EGFR).  It binds to the ATP-binding site of EGFR, thus inactivating the anti-apoptotic Ras signal transduction cascade preventing further growth of cancer cells.<span class="mw-ref" id="cite_ref-FDA-Gefitinib_7-0"><a href="#cite_note-FDA-Gefitinib-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><span class="mw-ref" id="cite_ref-8"><a href="#cite_note-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-9"><a href="#cite_note-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Lapatinib">Lapatinib</h3></summary>
    
<p>In March 2007, GlaxoSmithKline's drug <a href="Lapatinib.htm" tppabs="https://ptable.com/wiki/compounds/A/Lapatinib" title="Lapatinib">lapatinib</a> was approved by the U.S. FDA to treat advanced-stage or metastatic breast cancer in combination with Roche's <a href="Capecitabine.htm" tppabs="https://ptable.com/wiki/compounds/A/Capecitabine" title="Capecitabine">capecitabine</a>.  Lapatinib eliminates the growth of breast cancer stem cells that cause tumor growth.  The binding of lapatinib to the ATP-binding site in the EGFR and human epidermal growth factor receptor 2 (HER2) protein kinase domains inhibits signal mechanism activation (through reversible, competitive inhibition).<span class="mw-ref" id="cite_ref-FDA-Lapatinib_10-0"><a href="#cite_note-FDA-Lapatinib-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span><span class="mw-ref" id="cite_ref-11"><a href="#cite_note-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span><span class="mw-ref" id="cite_ref-European_Breast_Cancer_Conference_6_12-0"><a href="#cite_note-European_Breast_Cancer_Conference_6-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span><span class="mw-ref" id="cite_ref-pmid16418322_13-0"><a href="#cite_note-pmid16418322-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Erlotinib">Erlotinib</h3></summary>
    
<p>In May 2013, <a href="Erlotinib.htm" tppabs="https://ptable.com/wiki/compounds/A/Erlotinib" title="Erlotinib">erlotinib</a>, a drug manufactured by Astellas, was approved by the U.S. FDA to treat NSCLC patients with tumors caused by mutations of EGFR. The binding of erlotinib to the ATP-binding sites of the EGFR receptors prevents EGFR from producing phosphotyrosine residues (due to competitive inhibition), thus rendering the receptor incapable of generating signal cascades to promote cell growth.<span class="mw-ref" id="cite_ref-FDA-Erlotinib_14-0"><a href="#cite_note-FDA-Erlotinib-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span><span class="mw-ref" id="cite_ref-15"><a href="#cite_note-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Afatinib">Afatinib</h3></summary>
    
<p>In July 2013, the U.S. FDA approved afatinib, a drug developed by Boehringer Ingelheim, as an irreversible, competitive inhibitor of HER2 and EGFR kinases. While afatinib demonstrates a similar mechanism to laptinib in which it acts as an irreversible HER2 and EGFR inhibitor, afatinib has also shown activity against tyrosine kinases that have become resistant to gefinitib and erlotinib.<span class="mw-ref" id="cite_ref-FDA_16-0"><a href="#cite_note-FDA-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span></p>
<ul class="gallery mw-gallery-traditional">
<li class="gallerycaption">Quinazoline-containing drugs</li>
<li class="gallerybox" style="width: 175px;"><div class="thumb" style="width: 170px; height: 115px;"><figure-inline><img src="../I/m/Gefitinib_structure.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Gefitinib_structure.svg.png" data-file-width="1438" data-file-height="649" data-file-type="drawing" height="63" width="140"></figure-inline></div><div class="gallerytext"><a href="Gefitinib.htm" tppabs="https://ptable.com/wiki/compounds/A/Gefitinib" title="Gefitinib">Gefitinib</a> for treatment of non-small-cell lung carcinoma.</div></li>
<li class="gallerybox" style="width: 175px;"><div class="thumb" style="width: 170px; height: 115px;"><figure-inline><img src="../I/m/Lapatinib.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Lapatinib.svg.png" data-file-width="512" data-file-height="329" data-file-type="drawing" height="85" width="133"></figure-inline></div><div class="gallerytext"><a href="Lapatinib.htm" tppabs="https://ptable.com/wiki/compounds/A/Lapatinib" title="Lapatinib">Lapatinib</a> for treatment of advanced-stage or metastatic breast cancer.</div></li>
<li class="gallerybox" style="width: 175px;"><div class="thumb" style="width: 170px; height: 115px;"><figure-inline><img src="../I/m/Erlotinib.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Erlotinib.svg.png" data-file-width="1967" data-file-height="941" data-file-type="drawing" height="67" width="140"></figure-inline></div><div class="gallerytext"><a href="Erlotinib.htm" tppabs="https://ptable.com/wiki/compounds/A/Erlotinib" title="Erlotinib">Erlotinib</a>, an anti-tumor agent.</div></li>
<li class="gallerybox" style="width: 175px;"><div class="thumb" style="width: 170px; height: 115px;"><figure-inline><img src="../I/m/Afatinib_skeletal.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Afatinib_skeletal.svg.png" data-file-width="307" data-file-height="186" data-file-type="drawing" height="85" width="140"></figure-inline></div><div class="gallerytext">Afatinib for treatment of cancers resistant to gefinitib and erlotinib.</div></li>
</ul>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="See_also">See also</h2></summary>
    
<ul><li>Quinazolinone</li>
<li>Niementowski quinazoline synthesis</li></ul>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-Armarego-1"> <span id="mw-reference-text-cite_note-Armarego-1" class="mw-reference-text"><cite id="CITEREFArmarego1963" class="citation book cs1">Armarego, W. L. F. (1963). <i>Quinazolines</i>. <i>Advances in Heterocyclic Chemistry</i>. <b>1</b>. pp.<span>&nbsp;</span>253–309. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0065-2725%2808%2960527-9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0065-2725%2808%2960527-9'" tppabs="https://doi.org/10.1016%2FS0065-2725%2808%2960527-9" class="external text external">10.1016/S0065-2725(08)60527-9</a>. ISBN<span>&nbsp;</span><bdi>9780120206018</bdi>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/14087221  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/14087221'" tppabs="https://pubmed.ncbi.nlm.nih.gov/14087221" class="external text external">14087221</a>.</cite></span></li><li id="cite_note-Houben-Weyl-2"> <span id="mw-reference-text-cite_note-Houben-Weyl-2" class="mw-reference-text">Büchel, K. H., ed. <i>Methods of Organic Chemistry (Houben-Weyl): Additional and Supplementary Volumes to the 4th Edition.</i> New York: Georg Thieme Verlag Stuttgart, 2001.</span></li><li id="cite_note-3"> <span id="mw-reference-text-cite_note-3" class="mw-reference-text"><cite id="CITEREFShangMorris-NatschkeLiuGuo2018" class="citation journal cs1">Shang, XF; Morris-Natschke, SL; Liu, YQ; Guo, X; Xu, XS; Goto, M; Li, JC; Yang, GZ; Lee, KH (May 2018). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421866  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421866'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421866" class="external text external">"Biologically active quinoline and quinazoline alkaloids part I."</a> <i>Medicinal Research Reviews</i>. <b>38</b> (3): 775–828. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fmed.21466  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fmed.21466'" tppabs="https://doi.org/10.1002%2Fmed.21466" class="external text external">10.1002/med.21466</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421866  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421866'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421866" class="external text external">6421866</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/28902434  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/28902434'" tppabs="https://pubmed.ncbi.nlm.nih.gov/28902434" class="external text external">28902434</a>.</cite></span></li><li id="cite_note-4"> <span id="mw-reference-text-cite_note-4" class="mw-reference-text"><cite id="CITEREFShangMorris-NatschkeYangLiu2018" class="citation journal cs1">Shang, Xiao-Fei; Morris-Natschke, Susan L.; Yang, Guan-Zhou; Liu, Ying-Qian; Guo, Xiao; Xu, Xiao-Shan; Goto, Masuo; Li, Jun-Cai; Zhang, Ji-Yu; Lee, Kuo-Hsiung (September 2018). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105521  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105521'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105521" class="external text external">"Biologically active quinoline and quinazoline alkaloids part II"</a>. <i>Medicinal Research Reviews</i>. <b>38</b> (5): 1614–1660. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Fmed.21492  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Fmed.21492'" tppabs="https://doi.org/10.1002%2Fmed.21492" class="external text external">10.1002/med.21492</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0198-6325  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0198-6325'" tppabs="https://www.worldcat.org/issn/0198-6325" class="external text external">0198-6325</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105521  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105521'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105521" class="external text external">6105521</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/29485730  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/29485730'" tppabs="https://pubmed.ncbi.nlm.nih.gov/29485730" class="external text external">29485730</a>.</cite></span></li><li id="cite_note-Asif-5"> <span id="mw-reference-text-cite_note-Asif-5" class="mw-reference-text">Asif, M. <i>Chemical Characteristics, Synthetic Methods, and Biological Potential of Quinazoline and Quinazolinone Derivatives</i>, International Journal of Medicinal Chemistry, Article ID 395637, 2014. doi<span>:</span><a href="javascript:if(confirm('https://doi.org/10.1155%2F2014%2F395637  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1155%2F2014%2F395637'" tppabs="https://doi.org/10.1155%2F2014%2F395637" class="external text external">10.1155/2014/395637</a></span></li><li id="cite_note-Abstracts-6"> <span id="mw-reference-text-cite_note-Abstracts-6" class="mw-reference-text">Morgan, G.T., ed. <i>Abstract of Papers</i>. Journal of the Chemical Society. London: Gurney &amp; Jackson, 1904. Print.</span></li><li id="cite_note-FDA-Gefitinib-7"> <span id="mw-reference-text-cite_note-FDA-Gefitinib-7" class="mw-reference-text"><cite class="citation news cs1"><a href="javascript:if(confirm('http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/021399lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/021399lbl.pdf'" tppabs="http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/021399lbl.pdf" class="external text external">"Iressa(Gefitinib)"</a> <span class="cs1-format">(PDF)</span>. US Food and Drug Administration. 2 May 2003.</cite></span></li><li id="cite_note-8"> <span id="mw-reference-text-cite_note-8" class="mw-reference-text"><cite id="CITEREFLynchBellSordellaGurubhagavatula2004" class="citation journal cs1">Lynch, Thomas J.; Bell, Daphne W.; Sordella, Raffaella; Gurubhagavatula, Sarada; Okimoto, Ross A.; Brannigan, Brain W.; Harris, Patricia L.; Haserlat, Sara M.; Supko, Jeffrey G.; Haluska, Frank G.; Louis, David N.; Christiani, David C.; Settleman, Jeff; Haber, Daniel A (May 20, 2004). <a href="javascript:if(confirm('http://repository.cshl.edu/22429/1/EGFR%20Mutations.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://repository.cshl.edu/22429/1/EGFR%20Mutations.pdf'" tppabs="http://repository.cshl.edu/22429/1/EGFR%20Mutations.pdf" class="external text external">"Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non-Small-Cell Lung Cancer to Gefitinib"</a> <span class="cs1-format">(PDF)</span>. <i>NEJM</i>. <b>350</b> (21): 2129–39. doi:<a href="javascript:if(confirm('https://doi.org/10.1056%2Fnejmoa040938  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1056%2Fnejmoa040938'" tppabs="https://doi.org/10.1056%2Fnejmoa040938" class="external text external">10.1056/nejmoa040938</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15118073  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15118073'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15118073" class="external text external">15118073</a>.</cite></span></li><li id="cite_note-9"> <span id="mw-reference-text-cite_note-9" class="mw-reference-text">Takimoto CH, Calvo E. <a href="javascript:if(confirm('http://www.cancernetwork.com/cancer-management-11/chapter03/article/10165/1402628  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.cancernetwork.com/cancer-management-11/chapter03/article/10165/1402628'" tppabs="http://www.cancernetwork.com/cancer-management-11/chapter03/article/10165/1402628" class="external text external">"Principles of Oncologic Pharmacotherapy"</a> in Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ (Eds) <a href="javascript:if(confirm('http://www.cancernetwork.com/cancer-management-11/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.cancernetwork.com/cancer-management-11/'" tppabs="http://www.cancernetwork.com/cancer-management-11/" class="external text external">Cancer Management: A Multidisciplinary Approach</a>. 11 ed. 2008.</span></li><li id="cite_note-FDA-Lapatinib-10"> <span id="mw-reference-text-cite_note-FDA-Lapatinib-10" class="mw-reference-text"><cite class="citation news cs1"><a href="javascript:if(confirm('https://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/ucm129252.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/ucm129252.htm'" tppabs="https://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/ucm129252.htm" class="external text external">"Lapatinib"</a>. US Food and Drug Administration. 13 March 2007.</cite></span></li><li id="cite_note-11"> <span id="mw-reference-text-cite_note-11" class="mw-reference-text"><cite id="CITEREFWoodTruesdaleMcDonaldYuan2004" class="citation journal cs1">Wood ER, Truesdale AT, McDonald OB, Yuan D, Hassell A, Dickerson SH, Ellis B, Pennisi C,  et al. (2004). <a href="javascript:if(confirm('https://doi.org/10.1158/0008-5472.CAN-04-1168  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1158/0008-5472.CAN-04-1168'" tppabs="https://doi.org/10.1158/0008-5472.CAN-04-1168" class="external text external">"A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells"</a>. <i>Cancer Research</i>. <b>64</b> (18): 6652–9. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1158%2F0008-5472.CAN-04-1168  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1158%2F0008-5472.CAN-04-1168'" tppabs="https://doi.org/10.1158%2F0008-5472.CAN-04-1168" class="external text external">10.1158/0008-5472.CAN-04-1168</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15374980  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15374980'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15374980" class="external text external">15374980</a>.</cite></span></li><li id="cite_note-European_Breast_Cancer_Conference_6-12"> <span id="mw-reference-text-cite_note-European_Breast_Cancer_Conference_6-12" class="mw-reference-text"><cite id="CITEREFRodriguez,A.2008" class="citation conference cs1">Rodriguez,A. (April 2008). <a href="javascript:if(confirm('https://web.archive.org/web/20081126082044/http://www.ecco-org.eu/News/Press-room/Press-release/page.aspx/439?xf_itemId=265&xf_catId=27  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20081126082044/http://www.ecco-org.eu/News/Press-room/Press-release/page.aspx/439?xf_itemId=265&xf_catId=27'" tppabs="https://web.archive.org/web/20081126082044/http://www.ecco-org.eu/News/Press-room/Press-release/page.aspx/439?xf_itemId=265&xf_catId=27" class="external text external"><i>New type of drug shrinks primary breast cancer tumors significantly in just six weeks; research provides leads to a new target in cancer treatment – the cancer stem cell</i></a>. Archived from <a href="javascript:if(confirm('http://www.ecco-org.eu/News/Press-room/Press-release/page.aspx/439?xf_itemId=265&xf_catId=27  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ecco-org.eu/News/Press-room/Press-release/page.aspx/439?xf_itemId=265&xf_catId=27'" tppabs="http://www.ecco-org.eu/News/Press-room/Press-release/page.aspx/439?xf_itemId=265&xf_catId=27" class="external text external">the original</a> on 2008-11-26.</cite></span></li><li id="cite_note-pmid16418322-13"> <span id="mw-reference-text-cite_note-pmid16418322-13" class="mw-reference-text"><cite id="CITEREFNelsonDolder2006" class="citation journal cs1">Nelson MH, Dolder CR (February 2006). "Lapatinib: a novel dual tyrosine kinase inhibitor with activity in solid tumors". <i>Ann Pharmacother</i>. <b>40</b> (2): 261–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1345%2Faph.1G387  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1345%2Faph.1G387'" tppabs="https://doi.org/10.1345%2Faph.1G387" class="external text external">10.1345/aph.1G387</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16418322  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16418322'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16418322" class="external text external">16418322</a>.</cite></span></li><li id="cite_note-FDA-Erlotinib-14"> <span id="mw-reference-text-cite_note-FDA-Erlotinib-14" class="mw-reference-text"><cite class="citation news cs1"><a href="javascript:if(confirm('https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm352317.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm352317.htm'" tppabs="https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm352317.htm" class="external text external">"Erlotinib"</a>. US Food and Drug Administration. 14 May 2013.</cite></span></li><li id="cite_note-15"> <span id="mw-reference-text-cite_note-15" class="mw-reference-text"><cite id="CITEREFRaymondFaivreArmand2000" class="citation journal cs1">Raymond E, Faivre S, Armand J (2000). "Epidermal growth factor receptor tyrosine kinase as a target for anticancer therapy". <i>Drugs</i>. 60 Suppl 1: 15–23, discussion 41–2. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00003495-200060001-00002  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00003495-200060001-00002'" tppabs="https://doi.org/10.2165%2F00003495-200060001-00002" class="external text external">10.2165/00003495-200060001-00002</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11129168  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11129168'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11129168" class="external text external">11129168</a>.</cite></span></li><li id="cite_note-FDA-16"> <span id="mw-reference-text-cite_note-FDA-16" class="mw-reference-text"><cite class="citation news cs1"><a href="javascript:if(confirm('https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm360574.htm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm360574.htm'" tppabs="https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm360574.htm" class="external text external">"Afatinib"</a>. US Food and Drug Administration. 12 July 2013.</cite></span></li></ol></div></div>



<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2020-08-04" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=Quinazoline&oldid=971203128  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=Quinazoline&oldid=971203128'" tppabs="https://en.wikipedia.org/wiki/?title=Quinazoline&oldid=971203128">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>